Specific
to tendon tissue
The treatment is based upon the hypothesis that whilst tendon tissue
is constantly in a state of biological regeneration and degeneration
this process occurs slowly and should be in a state of equilibrium. However,
in many cases this is not the situation and the degenerative phase
runs ahead (at times significantly) of the regenerative phase. This
leaves the structure potentially vulnerable to mechanically induced
stress overload and ultimately breakdown. One reason for the
sluggish regenerative cycle has been identified as a slowing or blocking
of the cell to cell communication process. This process is,
to a degree controlled by electro-chemical signalling. The
treatment re-ignites this electro-chemical signalling process by
the precise application of a minute and cell specific sequenced electric
current.
In simple terms
this new treatment significantly increases the level of cellular
activity which in turn increases the rate of collagen production
that has the effect of reducing the incidence of chronic degeneration
(the major cause of injury) and promotes a quicker repair in tendons
that are damaged. In addition, the repair tissue is the same
type as the original tendon tissue (a type 1 collagen) not a scar-type
repair (type III collagen as normally happens with other treatments)
so reducing the chance of re-injury.
